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Objectives: To determine whether immune injury during acute cardiac 
rejection induces phenotypic modulation of arterial smooth muscle cells 
and lesion formation, we studied the expression of embryonic myosin 
heavy-chain isoform and degrees of intimal proliferation in aortas and 
coronary arteries of allografted rabbit hearts. Modulation of phenotype in 
arterial smooth muscle cells during acute vascular injury is a widely 
reported phenomenon, and proliferation and migration of medial smooth 
muscle cells contribute to development of intimal hyperplasia of arteries in 
response to immune injury. Methods: Rabbit hearts were heterotopically 
transplanted to the neck without immunosuppression. Hearts were har- 
vested at 2, 5, 7, and 10 days after transplantation. Proliferation of smooth 
muscle cells was assessed by bromodeoxyuridine labeling. Staining for 
immunohistochemical indicators was done with use of monoclonal antibod- 
ies that recognize T lymphocytes and all types of smooth muscle cells 
(SM1), adult type of smooth muscle cells (SM2), and embryonic myosin 
heavy-chain isoform. Intimal thickening and luminal narrowing were 
assessed with a computer-assisted vi eo image analysis system. Results: 
Intimal thickening and luminal narrowing in aortas and coronary arteries 
gradually increased in a time-dependent manner. The neointima thus 
formed consisted of proliferating smooth muscle cells positive for both SM1 
and embryonic myosin heavy-chain isoform and massive T lymphocyte 
accumulation. Intimal proliferation was more prominent in aortas and 
large epicardial coronary arteries than in the intramyocardial small 
coronary arteries. Conclusions: These findings suggest that allogeneic 
immune injury facilitates phenotypic modulation of smooth muscle cells, 
which may contribute to subsequent transplantation-associated heroscle- 
rosis. (J Thorac Cardiovasc Surg 1997;113:19-25) 
T ransplantation-associated atherosclerosis re- mains a serious complication that limits the 
long-term success of cardiac transplantation. TM The 
pathophysiologic processes of this accelerated ath- 
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erosclerosis and the stimuli that induce it remain 
unclear. Whatever the initiating factors involved in 
this process, disordered control of smooth muscle 
cell (SMC) homeostasis in vessel walls appears likely 
to promote the intimal hyperplasia that produces 
obstructive lesions in vessels. »' 6 
Kuro-o and associates 7 reported that rabbit SMCs 
express at least three types of myosin heavy-chain 
(MHC) isoforms: SM1, SM2, and SMemb. SM1 and 
SM2 are specific to SMCs, but SMemb is a non- 
muscle-type MHC isoform. 7' s SM1 is constitutively 
expressed from early development, but SM2 first 
appears after birth. SMemb is expressed predomi- 
nantly in the embryonic and neonatal stages and 
disappears in adults. These previous studies have 
clearly demonstrated the importance of these MHC 
isoforms as molecular markers in the identification 
of abnormally proliferating SMCs in vascular lesion 
formation. 
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It seems likely that in transplanted hearts, prolif- 
eration and migration of medial SMCs contribute to 
development of intimal hyperplasia of arteries in 
response to certain immune-mediated stimuli, s'6 
Libby and Tanaka s have presented evidence that the 
development of transplantation-associated arterio- 
sclerosis involves a cellular immune reaction to 
alloantigens on graft arterial cells. Indeed, Tanaka 
and colleagues 9'10 recently reported evidence for 
activation and prol i feration of SMCs in coronary 
arteries during acute rejection as determined by the 
expression of leukocyte adhesion molecules and 
tumor necrosis factor-a. To examine altered vascu- 
lar SMC phenotypes in greater detail, we studied the 
expression of MHC isoforms and characteristics of 
neointimal lesions of both aortas and coronary 
arteries during acute rejection in allografted rabbit 
hearts. 
Material and methods 
Animals. Japanese white rabbits (Saitama Experimen- 
tal Animal Lab., Saitama, Japan) were used as donors (1.5 
to 2.0 kg) and recipients (2.5 to 3.0 kg). All animals were 
monitored regularly for accidental contamination with 
infectious diseases. They were fed standard commercial 
rabbit chow and water ad libitum and were handled 
humanely in accordance with the regulations of the Ani- 
mal Care and Use Committee of the Tokyo Medical and 
Dental University. 
Heart transplantation. The heterotopic heart trans- 
plantation procedure used in this study was a modification 
of the technique originally described by Carrel. 11 The 
donor and recipient rabbits were anesthetized with intra- 
muscular injections of ketamine (35 mg/kg) and xylazine 
(7 mg/kg). A vertical incision was made on the anterior 
aspect of the neck of the recipient rabbit. The right 
common carotid artery and the external jugular vein were 
dissected free from surrounding tissues. Anticoagulation 
was achieved in the donor rabbit with an intravenous 
injection of heparin sodium (1000 IU). After thoracot- 
omy, the donor heart was removed rapidly after ligation of 
the venae cavae and pulmonary veins and immersed in 
cold saline solution. The transected ascending aorta of the 
donor heart was anastomosed end-to-side to the common 
carotid artery of the recipient, and the pulmonary artery 
of the donor was anastomosed to the external jugular vein 
of the recipient. A minilaparotomy was then done to 
insert an osmotic pump (Alza Corp., Palo Alto, Calif.) for 
continuous infusion of bromodeoxyuridine (20 mg/kg per 
day). The mean ischemic time, defined as the interval 
from removal of the graft to restoration of circulation, 
ranged from 30 to 40 minutes. The transplanted heart was 
examined aily by palpation. With the use of deep anes- 
thesia (pentobarbital, 50 mg/kg), the recipients were killed 
and their hearts excised at 2 (n = 7), 5 (n = 12), 7 (n = 
13), or 10 (n = 15) days after transplantation after 
intravenous injection of heparin sodium (1000 IU). Both 
the recipient and allograft hearts were perfused from the 
aorta with heparinized lactated Ringer's solution. Hearts 
were divided by three transverse sections at the basal, mid, 
and apical ventricular levels. Several ongitudinal sections 
of coronary ostia including both the aorta and the heart 
were made. These sections of the heart and the aorta were 
either immersed flxed in ethanol acetate or frozen in 
isopentane-cooled liquid nitrogen and optimal cutting 
temperature compound (O. C. T. compound, Miles, Inc., 
Elkhart, Ind.). 
General morphometry and histologic grading of rejec- 
tion. All ethanol acetate-fixed tissues were embedded in 
paraffin, cut into 6 /xm sections, and stained with hema- 
toxylin-eosin, Masson trichrome, and van Gieson elastin 
stains. Quantitative histologic analysis was done by two 
pathologists without knowledge of the protocol. Eaeh 
section was examined for grade of myocardial rejection 
and the presence and extent of luminal narrowing and 
intimal thickening. Morphometric analyses were done on 
van Gieson elastin-stained segments with use of a com- 
puter-assisted color image analyzer system (SP500F, 
Olympus Inc., Tokyo). For these analyses, five large 
epicardial coronary arteries (3 to 4 x 10/xm in diameter) 
and five intramyocardial small coronary arteries (10/xm in 
diameter) were selected. Intimal, medial, and luminal 
areas and lesion thickness were measured. Percentage 
luminal narrowing (%LN) and ratio of intimal thickness 
(%IT) were ealculated with the following formulas: 
%LN = intimal area/(intimal rea + luminal area) x 100 
and %IT = intimal thickness/(intimal thickness + medial 
thickness) x 100. Myocardial rejection was graded with 
use of the classification of the International Society for 
Heart and Lung Transplantation standarized grading sys- 
tem on a scale of 1 to 4.12 
Immunohistochemistry. The following antibodies were 
used to differentiate cell types. For SMCs, anti-muscle- 
specific actin antibody (HHF35, Enzo Bioehem., New 
York, N.Y.) was used, and the expression of MHC 
isoforms was examined with anti-SM1, anti-SM2, and 
anti-SMemb antibodies as previously reported. 7 For T 
lymphocytes and macrophages, L-11/13513 and RAM11 
(Enzo Diagnostic Inc.) were used. Endothelial cells were 
identified with use of anti-von Willebrand factor and 
anti-human endothelial cell JC/70A (Dakopatts, Copen- 
hagen). 
Immunoperoxidase studies were done with the use of a 
modified version of previously described techniques. 9 The 
sections were incubated overnight with antibodies and 
then the avidin-biotin complex immunoperoxidase proce- 
dure (Vectastain, Vector Lab. Inc., Burlingame, Calif.) 
was done. Antibody binding was visualized with 3,3'- 
diaminobenzidine (Sigma Chemical Co., St. Louis, Mo.) 
and sections were counterstained with methyl green or 
hematoxylin. 
The intensity and extent of staining of SMCs for 
SMemb and bromodeoxyuridine w re graded semiquan- 
titatively on a scale from 0 to 5 as follows: grade 0, no 
staining; grade 1, scattered and infrequent staining; grade 
2, scattered mild staining; grade 3, scattered moderate 
staining; grade 4, widespread staining; and grade 5, wide- 
spread and intense staining. 
Data analysis. All values are expressed as means plus 
or minus the standard deviation. Data were processed 
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Fig. 1. Expression of MHC isoforms and bromodeoxyuridine (BrdU) in allografted aorta at 10 days after 
transplantation. Serial sections of ascending aorta of transplanted heart display severe intimal thickening. 
SMl-positive SMCs are negative for SM2, but positive for SMemb. HE, Hematoxylin-eosin stain; EV, van 
Gieson elastin stain (original magnification ×400). 
with StatView software (StatView-J 4.02, Brainpower Inc., 
Calabasas, Calif.). Significant differences among groups 
were determined by one-way analysis of variance and 
Scheffe's comparison method. Changes from control val- 
ues were compared by the Mann-Whitney rank-sum test. 
Differences were considered significant when p < 0.05. 
Results 
Grades of rejection in transplanted hearts. The 
recipient hearts exhibited no myocytic necrosis or 
cell infiltration. In the transplanted heart, there was 
minimal ymphocytic infiltrate around vessels with- 
out myocytic necrosis at 2 days after transplantation. 
At 5 days after transplantation, diffuse perivascular 
and interstitial cell infiltrates was present, and myo- 
cytic necrosis gradually increased thereafter. On 
days 7 and 10 after transplantation, severe rejection 
with widespread myocytic necrosis was present. The 
histologic degrees of rejection by the International 
Society for Heart and Lung Transplantation grading 
s ale for allografts at 2, 5, 7, and 10 days after 
transplantation were 1.6 + 0.5, 2.8 _ 0.7, 3.4 -+ 0.5, 
and 4 _+ 0.0, respectively. 
Histologie examinafion. None of the recipient 
aortas or coronary arteries exhibited any intimal 
thickening, and none expressed SMemb or incorpo- 
rated bromodeoxyuridine. At 2 days after transplan- 
tation, there was also no intimal thickening or 
expression of SMemb in the SMCs in the donor 
aortas or coronary arteries. At 5 days after trans- 
plantation, intimal thickening mainly as a result of T 
cell accumulation was observed in the aorta. This 
type of intimal thickening was also observed in the 
large epicardial c0ronary artery. At 7 and 10 days 
after transplantation, intimal thickening of the aor- 
tas and the large coronary arteries became pro- 
nounced and circumferentially larger and was ac- 
companied by widespread, extensive infiltration by 
mononuclear cells and cells with highly vacuolated 
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Fig. 2. Expression of bromodeoxyuridine i  allografled 
aorta, epicardial large coronary arteries (large CA), and 
intramyocardial small coronary arteries (small CA) at 2, 5, 
7, and 10 days after transplantation. *p < 0.05 compared 
with aorta; ~p < 0.05 compared with large coronary 
arteries. 
cytoplasm. Most of the endothelial cells in the aorta 
were lost. These cells in the neointima were T cells, 
and RAM11-positive macrophages were observed 
sporadically. The highly vacuolated cells in the 
neointima of the aortas and the large coronary 
arteries were negative for SM2, but expressed actin, 
SM1, and SMemb (Fig. 1). The cells positive for 
anti-SMemb were also stained with bromodeoxyuri- 
dine. There were fewer cells positive for SMemb 
and bromodeoxyuridine i  the small coronary arter- 
ies than in the large coronary arteries. SMCs in 
arterioles did not express SMemb or incorporate 
bromodeoxyuridine. The degrees of expression of 
SMemb and bromodeoxyuridine in SMCs in the 
aorta, large epicardial coronary artery, and small 
intramyocardial coronary artery are illustrated in 
Figs. 2 and 3. 
Morphometrie analysis. In the aorta, percent- 
ages of both luminal narrowing and intimal thick- 
ness increased significantly over time from 2 days to 
10 days after transplantation. At 7 days after trans- 
plantation, percentages of luminal narrowing and 
intimal thickness of the small intramyocardial coro- 
nary artery were significantly smaller than those for 
the large epicardial coronary artery (Table I, Fig. 4). 
In addition, at 10 days after transplantation, per- 
centages of luminal narrowing and intimal thickness 
of the small intramyocardial coronary artery were 
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Fig. 3. Expression of SMemb in allografled aorta, epicar- 
dial large coronary arteries (large CA), and intramyocar- 
dial small coronary arteries (smalI CA) at 2, 5, 7, and 10 
days after transplantation. *p < 0.05 compared with aorta; 
?p < 0.05 compared with large coronary arteries. 
significantly smaller than those of the aorta and the 
large epicardial coronary artery (Table I, Fig. 4). 
Discussion 
The findings of previous experimental nd clinical 
studies have suggested that immune-mediated stim- 
uli induce transplantation-associated rteriosclero- 
sis.4, 5, 9, 10, 14, 15 However, clinical investigations dis- 
agree concerning the extent of correlation of the 
number of episodes or severity of acute rejection 
with the development of this disease. Tanaka and 
colleagues 9, 10 recently reported activation and pro- 
liferation of vascular SMCs during acute rejection 
with use of the same rabbit heterotopic transplan- 
tation model as our own, suggesting that acute 
cell-mediated rejection might alter SMC phenotypes 
in rabbit arteries and induce SMC proliferation, 
thereby contributing to lesion formation. We there- 
fore evaluated the expression of MHC isoforms of 
SMCs, which are molecular markers of phenotypic 
modulation of SMCs in arteries during acute rejec- 
tion. In this study, we found expression of SMemb 
and decreased expression of SM2 in most neointi- 
mal SMCs and in addition found occasional medial 
SMCs in the aortas and the large coronary arteries 
with striking accumulation of T lymphocytes. These 
findings suggest hat certain allogeneic immune- 
mediated stimuli during acute rejection modulate 
MHC isoforms to induce migration and prolifera- 
tion of SMCs. »' 9, 16 Possible candidates for inducers 
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Table I. Morphometric data for aorta and coronary arteries 
7Days 
Aorta Large CA Small CA 
10 Days 
Aorta Large CA Small CA 
External diameter (×10/xm) 330 _+ 48 41 _+ 0.2 10 _+ 0.07 
Area 
Medial (×105/xm 2) 44 _+ 5 3.2 _+ 0.4 0.41 .+ 0.05 
Intimal (×103 p~m 2) 298 _+ 31 9.8 ,+ 0.3 0.64 _+ 0.05 
Percent LN 7.1 ,+ 0.3 22.4 _+ 6.5 5.3 -+ 0.4* 
Thickness 
Medial (×10 ~m) 34 _+ 5 4.3 _+ 0.2 1.6 + 0.07 
Intimal (p~m) 4.1 _+ 0.5 1.1 _+ 0.08 0A7 ,+ 0.02 
Percent hickness 10.5 .+ 0.8 20.2 + 5.8 8.9 _+ 0.7* 
321 + 35 42 -+ 0.3 9.5 -+ 0.06 
42 -+ 4 3.3 -+ 0.6 0.42 -+ 0.4 
725 -+ 52 13 -+ 0.4 0.71 "+ 0.03 
17.5 "+ 0.4 28.7 -+ 8.5 9.5 -+ 0.6*t 
35 .+ 6 4.5 -+ 0.7 1.5 -+ 0.05 
9.7 .+ 0.8 2.9 -+ 0.3 0.2 -+ 0.06 
21.7 --+ 2.5 39.7 -+ 0.7 11.8 -+ 0.8"t 
Values are means plus or minus the standard eviation. CA, Coronary artery; LN, luminaI narrowing. 
*p < 0.05 compared with large coronary artery. 
tp < 0.05 compared with aorta. 
of isoform modulation of SMCs include cytokines 
and growth factors released from activated T 
lymphocytes that have infiltrated into vessels and 
from vascular endothelial cells and SMCs them- 
selves.», 9, 16 
Differential expression of MHC. Another issue 
concerning expression of MHC isoforms in this 
study is why facilitated immature phenotype expres- 
sion of SMCs was less pronounced in the coronary 
artery than in the aorta. We suspect that a differen- 
tiation or modulation process may affect he heter- 
ogenous formation of immature type of SMCs. In 
support of this, Tanaka and colleagues 9' 10 reported 
that heterogenous activation of endothelial cells and 
SMCs, as determined by the expression of vascular 
cell adhesion molecule 1, intracellular adhesion 
molecule 1, and tumor necrosis factor-a, was more 
rapid and more pronounced in the aorta than in the 
coronary artery during acute rejection in rabbit 
allograft hearts. In contrast, the possibility exists 
that normal adult rabbit arterial media is composed 
of phenotypically heterogenous SMC populations or 
stemlike cell compartments that increase in size to 
perform various functions in response to different 
stimuli)7, 18 Zanellato and coworkers 17 identified 
two SMC populations in the medial ayer of normal 
adult rabbit aorta: cells that contained smooth mus- 
cle myosin exclusively and cells with both smooth 
muscle and nonmuscle myosin (200 kDa) isoforms. 
The size of the cell population with double myosin 
isoform content increased markedly over the course 
of experimental therogenesis. Frid, Moiseeva, and 
Stenmark 18also obtained evidence that suggested 
the presence of complex, site-specific heterogeneity 
in the structure and cellular composition of the 
bovine main pulmonary artery. They reported the 
presence of an abundant nonmuscle-like cell or 
immature SMC population within the mature arte- 
rial media. Given these observations of SMC heter- 
ogeneity in mature vessels and the findings of the 
present study, it seems reasonable to speculate that 
a specific immature type of SMC subpopulation that 
is not labeled by anti-SMemb antibody but expresses 
other nonmuscle myosin isoforms may be more 
abundant inthe aorta than in the coronary artery. In 
fact, a difference xists in the expression of SMemb 
between human and rabbk vascular MHC. 19 In 
rabbits, SMemb quickly disappeared at 4 months 
after birth, whereas in human beings, SMemb was 
detected eren in adults in aorta and coronary arter- 
ies. However, smaller-sized arteries, including the 
vasa vasorum of the aorta or intramyocardial coro- 
nary arteries, were negative for SMemb. 19 Thus 
further analysis may be required to determine the 
relevance of the findings of the present study to 
human cardiac transplantation. 
Differential intimal thickening during aeute re- 
jection in various types of arteries. Our fmding of 
greater annular intimal thickening in the epicardial 
large coronary artery than in the intramyocardial small 
coronary artery is quite different from those findings 
described in previous studies of chronic transplanta- 
tion-associated arteriosclerosis. 1-3'2° Johnson and as- 
sociates 2,3 reported that transplant coronary artery 
disease of long-term allografts is orten dilNse, espe- 
cially in distal vessels. Lin and colleagues 21also found 
that percentage luminal narrowing in human trans- 
plant recipients did not differ between proximal and 
distal segments in the left anterior descending coro- 
nary arteries (46% proximally versus 41% distally) in a 
study of 25 allografts at autopsy and explants at a mean 
of 490 days after transplantation. Disparity in time of 
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Fig. 4. Sections of aorta and coronary arteries in allografted heart at10 days after transplantation stained 
with hematoxylin-eosin stain. A, Longitudinal section of aorta and ostium of left coronary artery (LCA) 
(original magnification ×40); B, cross-section f proximal left anterior descending coronary artery (original 
magnification ×100); C, cross-section of intramyocardial small coronary artery (original magnification 
×400); D, cross-section f arteriole (original magnification ×400). 
study after t ansplantation, and also differences among 
clinical human transplantation a d experimental mod- 
els with or without hyperlipidemia, may have ac- 
counted for the differences in results obtained. In 
addition, the lack of immunosuppression compared 
with other animal models that examined the develop- 
ment of atherosclerosis may explain the obtained 
different results. However, several reports have sug- 
gested that proliferative intimal lesions during acute 
vascular rejection are not caused by accelerated 
atherogenesis, but represent a separate disease ntity 
in which infiltrating T lymphocytes may play a critical 
role in initiating intimal SMC accumulation and pro- 
liferation. 4'22-24 Norman and associates 23 demon- 
strated proliferation of vacuolated immature SMCs in 
the neointima accompanied by mainly T lymphocyte 
infiltration during acute rejection in four transplanted 
human hearts surviving 10 to 82 days. They also 
reported that acute vascular rejection was present 
in the main coronary arteries and the major 
epicardial branches, but was usually not observed 
in the intramyocardial vessels. In the present 
study, we also found that highly vacuolated cells 
were present in the neointima of the aortas and 
the large coronary arteries that express SMemb. 
Accordingly, it seems likely that acute vascular 
rejection occurred predominantly in large coro- 
nary arteries, whereas chronic transplantation-asso- 
ciated atherosclerosis occurred diffusely or was 
more pronounced in small coronary arteries. A1- 
though it is difficult to clarify in what fashion acute 
annular lymphocyte accumulation changes to the 
formation of the typical chronic myointimal lesions, 
and these two lesions are probably different stages in 
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the natural  history of immune-mediated vascular 
injury, acute vascular rejection may be pathologi- 
cally distinct from chronic vascular ejection. 
Conelusion. The findings of the present study 
elucidate one aspect of the pathogenesis of graft 
atherosclerosis: that allogeneic immune injury facil- 
itates phenotypic modulat ion of SMCs, which may 
contribute to subsequent transplantation-associated 
atherosclerosis. However, the questions of how ep- 
isodes of acute rejection affect the development of
late-stage transplantation-associated graft athero- 
sclerosis and why heterogeneity of intimal lesion is 
present among arteries remain to be answered. 
We acknowledge Toshiyuki Maruyama, MD, for his 
consultation regarding statistical analysis. 
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